Bnei Zion
Haifa, 3339123, Israel
NCT Number: NCT03600519
Primary objectives:
To compare between retinal measurements, done by the NOTAL-OCT V2.5 device and a commercial OCT.
Secondary objectives:
1. To evaluate the level of agreement between the NOTAL-OCT V2.5 and a commercial OCT in the presence of fluid as identified in the OCT images, in the central 10 degrees of the macula. 2. To evaluate the repeatability of the NOTAL-OCT V2.5
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Haifa, 3339123, Israel
Study population:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
a- Ability and agreement to give informed consent (IC) b -Diagnosis of AMD or DR in SE by OCT c- Ability to undergo OCT scans d- VA of 20/400 (6/120) or better in SE
AMD Patients
Other names: OCT scan
Time frame: less than an hour
measurements of retinal thickness.
Notal Vision Ltd.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07424235
AMD, Age Related Macular Degeneration
View Trial DetailsNCT07375901
AMD, Eye Diseases
Odesa, Ukraine
View Trial DetailsNCT03845582
AMD, Age Related Macular Degeneration
Phoenix, Arizona, United States
View Trial DetailsNCT03803631
AMD, Exudative Macular Degeneration
Bordeaux, France
View Trial Details